Видео ютуба по тегу Aflibercept

Aflibercept 8 mg Shows Promise in Reducing Injection Burden | AAO 2025
Aflibercept 8 mg Shows Promise in Reducing Injection Burden | AAO 2025
Using Aflibercept to Extend Treatment of Central Retinal Vein Occlusions
Using Aflibercept to Extend Treatment of Central Retinal Vein Occlusions
Efficacy and Safety of Intravitreal Aflibercept Treat and-Extend Regimens
Efficacy and Safety of Intravitreal Aflibercept Treat and-Extend Regimens
Unpacking Eylia - Aflibercept
Unpacking Eylia - Aflibercept
Deepak Sambhara, MD: Impact of CRT on Aflibercept 8 mg Outcomes in DME
Deepak Sambhara, MD: Impact of CRT on Aflibercept 8 mg Outcomes in DME
DRCR Protocol AC results Aflibercept Monotherapy or Bevacizumab First for... Dr. Chirag D. Jhaveri
DRCR Protocol AC results Aflibercept Monotherapy or Bevacizumab First for... Dr. Chirag D. Jhaveri
Jean-François Korobelnik, AAO 2018 – Aflibercept and the APOLLON study
Jean-François Korobelnik, AAO 2018 – Aflibercept and the APOLLON study
Aflibercept Injection for Nonproliferative Diabetic Retinopathy
Aflibercept Injection for Nonproliferative Diabetic Retinopathy
AIOC2017 - Sponsored Aflibercept(EYLEA)NewAnti-VEGF in the Market(18.02.2017/12:00-13:25/HALL: D
AIOC2017 - Sponsored Aflibercept(EYLEA)NewAnti-VEGF in the Market(18.02.2017/12:00-13:25/HALL: D
Sean Adrean, MD: Impact of Baseline VA on Aflibercept 8 mg Outcomes in DME
Sean Adrean, MD: Impact of Baseline VA on Aflibercept 8 mg Outcomes in DME
Quan Dong Nguyen on Pioneering Aflibercept, Ranibizumab, and Sirolimus
Quan Dong Nguyen on Pioneering Aflibercept, Ranibizumab, and Sirolimus
EURETINA 2018 - Efficacy of SubLiminal laser in IPCV Aflibercept resistant cases
EURETINA 2018 - Efficacy of SubLiminal laser in IPCV Aflibercept resistant cases
ANTIVEGF при диабетической ретинопатии | ранибизумаб, бевацизумаб, афлиберцепт | PRN, лечение и п...
ANTIVEGF при диабетической ретинопатии | ранибизумаб, бевацизумаб, афлиберцепт | PRN, лечение и п...
Faricimab vs aflibercept in patients with DME: Jennifer Lim, ARVO 2023
Faricimab vs aflibercept in patients with DME: Jennifer Lim, ARVO 2023
Patient Selection for Aflibercept in Advanced CRC
Patient Selection for Aflibercept in Advanced CRC
#афлиберцепт | Применение, дозировка, побочные эффекты и механизм действия | Eylea
#афлиберцепт | Применение, дозировка, побочные эффекты и механизм действия | Eylea
Raj Maturi: Sirolimus in Conjunction With Aflibercept
Raj Maturi: Sirolimus in Conjunction With Aflibercept
Dr. Ruff on the VELOUR Trial Analyzing Ziv-Aflibercept in mCRC
Dr. Ruff on the VELOUR Trial Analyzing Ziv-Aflibercept in mCRC
AIOS2025-GP179-Advancing DME Standards of Care with Aflibercept 8mg in the Real World
AIOS2025-GP179-Advancing DME Standards of Care with Aflibercept 8mg in the Real World
Anat Loewenstein Discusses UNRAVEL Trial of Ranibizumab and Aflibercept
Anat Loewenstein Discusses UNRAVEL Trial of Ranibizumab and Aflibercept
Aflibercept Dose in Polypoidal Choroidal Vasculopathy
Aflibercept Dose in Polypoidal Choroidal Vasculopathy
aflibercept_111709
aflibercept_111709
Role of the VEGF Inhibitor Aflibercept in Metastatic Colorectal Cancer
Role of the VEGF Inhibitor Aflibercept in Metastatic Colorectal Cancer
Dr. Chan Discusses the VEGF-Trap Agent Aflibercept
Dr. Chan Discusses the VEGF-Trap Agent Aflibercept
Cost-effectiveness of Aflibercept vs Bevacizumab-First Therapy for Diabetic Macular Edema
Cost-effectiveness of Aflibercept vs Bevacizumab-First Therapy for Diabetic Macular Edema